Medical Devices

With a new patent for its AI-powered VVC device, Zero Candida is betting on smart technology to solve a persistent health issue where drugs often fail.

A new medical device just debuted in the U.S., but the real story is the strategy. How a small Arizona startup is using precision engineering to challenge giants.

A new partnership brings FDA-authorized home ultrasounds to virtual care, aiming to reach millions of women in 'maternity deserts' with vital prenatal monitoring.

Valgen Medtech's dual EU approval for its heart valve device isn't just a clinical win; it's a tremor in the global medical technology landscape.

With its U.S. launch underway, Nyxoah is betting its innovative Genio system can unseat an industry giant. But can it chart a path to profitability?

A new law makes Illinois a pioneer, mandating Medicaid coverage for predictive blood tests. Can this tech-driven policy shift the tide on maternal health?

Dynacare's new at-home hormone tests promise unprecedented access and privacy. But are Canadians ready to navigate their health data outside the clinic?

A medical breakthrough in neurostimulation could dramatically increase the supply of lungs for transplant, tackling a critical shortage and saving lives.

With 40M more patients now covered, Kerecis's fish-skin technology is set for accelerated adoption, driven by powerful clinical data and payor confidence.

In two years, XERF has dominated the skin tightening market. We explore the strategy, tech, and cultural shift behind its meteoric, resilient rise.

An EY award for Rhythm Express founders highlights a deeper story of strategic innovation, patient-centric design, and the future of remote health monitoring.

A neurotech startup just hired a 20-year Cigna veteran. It’s not just a new advisor; it's a bold strategy to crack the insurance code for mental health.

For decades, newborns with a common foot condition faced painful casting. Now, a simple, FDA-approved brace is disrupting pediatric care and bringing relief.

A new deal between Parker Labs and Premier Inc. isn't just business. It's a critical look at how GPOs and new tech dictate infection control for millions.

Access Vascular and Medline are betting on a new hydrogel catheter to cut costly complications. Can this blend of advanced biomaterials and scale change care?

Teleflex launches a pivotal trial for a magnesium stent that vanishes in a year. Can it erase the memory of past failures and redefine cardiovascular care?

A pivotal NCCN guideline update for bladder cancer validates Natera's Signatera test, ushering in a new era of personalized, MRD-guided cancer treatment.

BD's new contract with purchasing giant Vizient for its CentroVena One™ system isn't just a product win; it's a strategic maneuver to redefine market standards.

Spotlight Medical's myStage Dx secures tough IVDR CE mark, using AI on standard lab slides to help doctors pinpoint which patients can safely avoid chemo.

With a $43M funding boost, Irish innovator CroíValve is expanding trials for its unique 'Adaptive Coaptation' device, aiming to transform treatment for millions.